ABOUT US

The Team

Experienced drug development professionals and experts in the field of PAH and BMPs

The Board

Scientific Advisory Board

Investors

Morphogen-IX was founded in 2015 with investment from Medicxi, Cambridge Innovation Capital and Cambridge Enterprise

 

Developing BMPs as novel treatments for pulmonary arterial hypertension